Patent holdings for IPC class C07D 257/04

Total number of patents in this class: 1122

10-year publication summary

92
72
65
67
71
68
57
55
42
20
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Sumitomo Chemical Company, Limited
9043
37
Theravance Biopharma R&D IP, LLC
456
26
Novartis AG
10744
22
Bristol-myers Squibb Company
4880
19
Allergan, Inc.
2347
17
SK Biopharmaceuticals Co., Ltd.
262
13
Nippon Soda Co., Ltd.
895
12
Rigel Pharmaceuticals, Inc.
538
11
Viamet Pharmaceuticals, Inc.
39
11
F. Hoffmann-La Roche AG
7947
10
Bayer Cropscience AG
2040
10
Global Blood Therapeutics, Inc.
181
10
Zhejiang Huahai Pharmaceutical Co., Ltd.
209
10
Board of Regents, The University of Texas System
5808
9
Pacific Scientific Energetic Materials Company
50
9
Reata Pharmaceuticals, Inc.
123
9
Bayer Pharma AG
1053
8
Neurosearch A/S
185
8
The Regents of the University of California
19961
7
Boehringer Ingelheim International GmbH
4642
7
Other owners 857